Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer

DOI10.1080/01621459.2011.641416zbMath1328.62601OpenAlexW2167371237WikidataQ36206859 ScholiaQ36206859MaRDI QIDQ4916481

Randall E. Millikan, Xihong Lin, Lu Wang, Peter F. Thall, Andrea G. Rotnitzky

Publication date: 22 April 2013

Published in: Journal of the American Statistical Association (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3433243

zbMATH Keywords

efficiencysimultaneous confidence intervalscausal inferenceinverse probability weightingmarginal structural modelsinformative dropoutoptimal regime

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Sequential statistical analysis (62L10)

Related Items

Tree-based reinforcement learning for estimating optimal dynamic treatment regimes, Estimation of the optimal regime in treatment of prostate cancer recurrence from observational data using flexible weighting models, A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes, Adaptive contrast weighted learning for multi‐stage multi‐treatment decision‐making, Optimal dynamic treatment regime estimation using information extraction from unstructured clinical text, Estimating Tree-Based Dynamic Treatment Regimes Using Observational Data with Restricted Treatment Sequences, A Bayesian decision framework for optimizing sequential combination antiretroviral therapy in people with HIV, Simultaneous confidence regions and weighted hypotheses on parameter arrays, Simultaneous confidence bands for restricted logistic regression models, Doubly-robust dynamic treatment regimen estimation via weighted least squares, Treatment Evaluation With Multiple Outcome Periods Under Endogeneity and Attrition, Stochastic Tree Search for Estimating Optimal Dynamic Treatment Regimes

Cites Work

• Efficient design and inference for multistage randomized trials of individualized treatment policies
• Bayesian inference for causal effects: The role of randomization
• Estimation of Survival Distributions of Treatment Policies in Two-Stage Randomization Designs in Clinical Trials
• Optimal Estimator for the Survival Distribution and Related Quantities for Treatment Policies in Two‐Stage Randomization Designs in Clinical Trials
• Marginal Mean Models for Dynamic Regimes
• Selecting Therapeutic Strategies Based on Efficacy and Death in Multicourse Clinical Trials
• Optimal Dynamic Treatment Regimes
• A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
• Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data